Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Carenostics logo — Addressing the underdiagnosis, undertreatment, and health in...

Carenostics

Addressing the underdiagnosis, undertreatment, and health inequities of chronic disease using AI and ML

Founded 2021 United States Philadelphia, United States 13 employees Seed Total: $5.00M AI, Biotechnology +2

General Information

Company Name Carenostics
Founded Year 2021
Location United States Philadelphia, United States
Employees 13
Industries AI, Biotechnology, Health Care +1
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Carenostics. To contact Carenostics, visit carenostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Carenostics compare?

A PDF of Carenostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Carenostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Carenostics

Carenostics, founded in 2021, is a dynamic player in the intersection of AI, Biotechnology, and Health Care. The company is headquartered in the United States and is dedicated to overcoming the challenges of underdiagnosis, undertreatment, and health inequities in chronic disease through advanced AI and ML technologies.

Carenostics develops AI solutions aimed at facilitating earlier clinical intervention for chronic diseases. By integrating machine learning models with existing provider EHRs, the company aids physicians in identifying undiagnosed chronic diseases, monitoring patient decline, and aligning treatment with evidence-based guidelines. Their flagship product, CKDx, targets the eradication of undiagnosed chronic kidney disease while addressing disparities affecting minority populations.

In their latest funding milestone, Carenostics secured a $5.00M Seed Round on September 13, 2023, supported by notable investors including Gaingels, GreatPoint Ventures, M13, and Kurt Hilzinger.

Business keywords: Healthcare AI, Chronic Disease Management, Clinical Decision Support, Predictive Analytics, Health Equity, Chronic Kidney Disease, Electronic Health Records, Diagnostics, Risk Stratification, Disease Intervention, Healthtech Solutions, Healthcare Partnerships, Health Inequities

Services & Products

AI-driven clinical decision support
Early detection and intervention solutions
Deployment in health systems

Target Customers

Healthcare providers Clinicians Health systems Hospitals

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $5.00M 4
Gaingels GreatPoint Ventures M13
Gaingels, GreatPoint Ventures +2
13 Sep 2023

Carenostics Alternatives & Competitors

View All Alternatives
Carenostics vs
Renalytix
Renalytix United States

Transforming kidney disease care with one simple blood test.

IPO
54 employees
AI, Biotechnology
Compare Carenostics vs Renalytix
Carenostics vs
dehaze
dehaze Germany

Detecting chronic diseases before symptoms occur.

Seed
15 employees
AI, Health Care
Carenostics vs
UpDoc
UpDoc United States

Pioneering Remote Patient Intervention | Augmenting Clinical Care with AI

Seed
16 employees
AI, Health Care
View all alternatives

FAQ About Carenostics

Addressing the underdiagnosis, undertreatment, and health inequities of chronic disease using AI and ML
Carenostics was founded in 2021.
Carenostics is headquartered in Philadelphia, United States.
Carenostics operates in AI, Biotechnology, Health Care and Machine Learning. Its work centres on Healthcare AI, Chronic Disease Management, Clinical Decision Support and Predictive Analytics. Its customers include Healthcare providers, Clinicians and Health systems.
Carenostics has approximately 13 employees.
Carenostics has completed 1 funding round, raising a total of $5.00M. The latest funding stage is Seed.
Carenostics offers: AI-driven clinical decision support, Early detection and intervention solutions, Deployment in health systems.
Top alternatives and competitors to Carenostics include Renalytix, dehaze, UpDoc, HEALWELL AI (TSX: AIDX), Tesu Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Carenostics and Renalytix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Carenostics, https://bouncewatch.com/company/carenostics, updated 14 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes